|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07H 7/04 | (2006.01) |
| C07H 15/207 | (2006.01) | ||
| A61K 31/7034 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Patento numeris | 3045466 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15181545.3 |
| Europos patento paraiškos padavimo data | 2007-06-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-07-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-12-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 817118 P | 2006-06-28 | US | |
| 765481 | 2007-06-20 | US |
| (72) |
GOUGOUTAS, Jack Z., US
NIRSCHL, Alexandra A., US
SINGH, Janak, US
DIMARCO, John D., US
LOBINGER, Hildegard, DE
RAMAKRISHNAN, Srividya, US
DESHPANDE, Prashant P., US
BIEN, Jeffrey T., US
LAI, Chiajen, US
WANG, Chenchi, US
RIEBEL, Peter, DE
GROSSO, John Anthony, US
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | (2S,3R,4S,5S,6R)-2-[4-CHLORO-3-(4-ETHOXY-BENZYL)-PHENYL]-6-HYDROXYMETHYL-2-METHOXY-TETRAHYDRO-PYRAN-3,4,5-TRIOL PROPYLENE GLYCOL SOLVATE AS SGT2 INHIBITOR FOR THE TREATMENT OF DIABETES |
| (2S,3R,4S,5S,6R)-2-[4-CHLORO-3-(4-ETHOXY-BENZYL)-PHENYL]-6-HYDROXYMETHYL-2-METHOXY-TETRAHYDRO-PYRAN-3,4,5-TRIOL PROPYLENE GLYCOL SOLVATE AS SGT2 INHIBITOR FOR THE TREATMENT OF DIABETES |